Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079950
Status:
SUSPENDED
Last Update Posted:
2012-09-06
First Post:
2004-03-18
Brief Title:
Efficacy and Safety Evaluation of Pegamotecan PEG-camptothecin in Advanced or Metastatic Soft Tissue Sarcoma
Sponsor:
Enzon Pharmaceuticals Inc
Organization:
Enzon Pharmaceuticals Inc
Organization Data
Organization:
Enzon Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
CAM-9009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Enzon Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Senior Director Regulatory Affairs
Old Organization:
Enzon Pharmaceuticals